お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
900628

医薬品における連続生産 (CM):ジェネリック医薬品市場への影響

Continuous Manufacturing in Pharmaceuticals: Implications for the Generics Market

出版日: | 発行: BCC Research | ページ情報: 英文 44 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=109.37円
医薬品における連続生産 (CM):ジェネリック医薬品市場への影響
出版日: 2019年07月26日
発行: BCC Research
ページ情報: 英文 44 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、医薬品・バイオ医薬品市場における連続生産 (CM) の導入に関する展望を示しており、市場展望、世界市場の動向分析・実績データ・推計・CAGR予測、米国FDAの役割、ジェネリック医薬品市場と将来のCM動向、および特許情勢などについて分析しています。

第1章 技術ハイライト・市場展望

  • 連続生産とは?
  • 医薬品産業にとってCM (連続生産) はどのように有益か?
  • CMの人気の高まりにおけるFDAの役割とは?
  • CMの導入を促進するその他の要因とは?
  • CMの本格的な導入に未だ消極的な医薬品企業は?
  • ジェネリック医薬品市場とCM
  • 医薬品・バイオ医薬品におけるCMの市場展望
  • CMにおけるイノベーションを明らかにする簡単な特許分析
  • CM市場における主要企業
  • 情報ソース
  • 調査手法
  • アナリストの経歴
  • 関連レポート

BBC Researchについて

図表

List of Tables

  • Table 1: Continuous Manufacturing vs. Batch Manufacturing
  • Table 2: FDA Approved Continuously Manufactured Drugs
  • Table 3: Collaborations and Partnerships in the Continuous Manufacturing Market, 2017 to Sept. 2018
  • Table 4: FDA Guidance Analysis
  • Table 5: Global Market for Continuous Manufacturing, by Type, Through 2024
  • Table 6: Global Market Shares of Continuous Manufacturing, by Type, 2018
  • Table 7: Global Market for Continuous Manufacturing, by End User, Through 2024
  • Table 8: Global Market Shares of Continuous Manufacturing, by End User, 2018
  • Table 9: Global Market for Continuous Manufacturing, by Region, Through 2024
  • Table 10: Global Market Shares of Continuous Manufacturing, by Region, 2018
  • Table 11: Patents Issued on Continuous Manufacturing, 2017 to June 28, 2019
  • Table 12: Patents Issued on Continuous Manufacturing, by Type, 2017 to June 28, 2019
  • Table 13: Patents Issued on Continuous Manufacturing, by Assignee Type, 2017 to June 28, 2019
  • Table 14: Leading Manufacturers/Suppliers of CM Systems/Technologies, 2018
  • Table 15: Market Shares of Leading Manufacturers/Suppliers of CM Systems/Technologies, 2018

List of Figures

  • Figure 1: Pharmaceutical Continuous vs. Batch Manufacturing Process
  • Figure 2: Global Market for Continuous Manufacturing, by Type, 2017-2024
  • Figure 3: Global Market Shares of Continuous Manufacturing, by Type, 2018
  • Figure 4: Global Market for Continuous Manufacturing, by End User, 2017-2024
  • Figure 5: Global Market Shares of Continuous Manufacturing, by End User, 2018
  • Figure 6: Global Market for Continuous Manufacturing, by Region, 2017-2024
  • Figure 7: Global Market Shares of Continuous Manufacturing, by Region, 2018
  • Figure 8: Patents Issued on Continuous Manufacturing, 2017 to June 28, 2019
  • Figure 9: Patents Issued on Continuous Manufacturing, by Type, 2017 to June 28, 2019
  • Figure 10: Patents Issued on Continuous Manufacturing, by Assignee Type, 2017 to June 28, 2019
  • Figure 11: Market Shares of Leading Manufacturers/Suppliers of CM Systems/Technologies, 2018
目次
Product Code: PHM214A

Report Highlights:

This report presents a perspective on the adoption of continuous manufacturing technologies by pharmaceuticals, the role of the FDA and implications for the generics sector.

Report Includes:

  • A market outlook of Continuous Manufacturing (CM) in pharmaceuticals and biopharmaceuticals market
  • Analyses of global CM market trends, with data from 2017-2018, estimates for 2019 and projections of CAGRs through 2024
  • Information on the role of U.S. FDA in the growing popularity of CM, the changing mindset of pharmaceutical sector, and other factors that are impacting the adoption of CM in pharmaceuticals sector
  • A look at generic drugs market and future trends for CM
  • Patent analysis highlighting the innovation in CM

Table of Contents

Chapter 1 - T- echnology Highlights and Market Outlook

  • What is Continuous Manufacturing?
  • How is CM Beneficial to the Pharmaceutical Industry?
    • What is the Status of Continuous Bioprocessing?
    • Industry Examples
  • What is FDA's Role in the Growing Popularity of CM?
  • What Other Factors Are Driving the Adoption of CM?
    • Growing Demand for Drugs
    • Desire to Reduce Costs and Increase Product Quality
    • PAT Guidance
    • Drive Toward Digitalization
    • Partnerships and Collaborations
    • Innovation in Technology
  • Which Pharmaceuticals Are Still Reluctant to Introduce CM at Full Scale?
    • Traditional Mindset
    • Cost of Transformation
    • CM Not Suitable for All Product Types
    • Requirement of Skilled Personnel
    • Lack of Experience and Data
  • Generics Drug Market and CM
    • Generic Drugs Compete with the Branded Drugs
    • Manufacturing Process is the Deciding Factor
    • Lurking Issues for the Generics Sector
    • Is Continuous Manufacturing the Solution for Generics Manufacturers?
    • Latest FDA Guidance-What is the Future?
  • Market Outlook for CM in Pharmaceuticals and Biopharmaceuticals
    • Market by Type
    • Market by End User
    • Market by Region
  • Brief Patent Analysis Highlighting Innovation in CM
    • Patents by Year
    • Patents by Type
    • Patents by Assignee
  • Major Players in the CM Market
    • Market Shares
  • Information Sources
  • Methodology
  • Analyst's Credentials
  • Related BCC Research Reports
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.